N/A Completed N=46 Randomized Single-blind Treatment

Morning Light Treatment for Traumatic Stress: The Role of Amygdala Reactivity

Source: ClinicalTrials.gov NCT04117347 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Mar 2024

Primary outcomePrimary: Change in Amygdala Reactivity as Measured by Blood-oxygen-level-dependent (BOLD) Functional Magnetic Resonance Imaging (fMRI) Signal — 0.1287; 0.1532; 0.2134; 0.1048 beta weights

Summary

The purpose of this study is to determine the effect of different amounts of time of morning light on brain emotional processing.

Outcome Measures

Outcome	Result	p-value
PRIMARY Change in Amygdala Reactivity as Measured by Blood-oxygen-level-dependent (BOLD) Functional Magnetic Resonance Imaging (fMRI) Signal	0.1287; 0.1532; 0.2134; 0.1048; 0.1248; 0.0806	—

Eligibility Criteria

Inclusion Criteria

Meets criteria for traumatic stress
Normal or corrected to normal vision
Right-handed
Fluency in English
Physically able to travel for study visit attendance

Exclusion Criteria

Significant chronic uncontrolled disease (e.g. uncontrolled diabetes, advanced liver disease, cancer, etc.)
Severe hearing problem
Intellectual disability or serious cognitive impairment
Inability to tolerate enclosed spaces (e.g. the MRI machine)
Ferrous-containing metals within the body
Pregnant, trying to get pregnant, or breastfeeding
Epilepsy
Other research participation
Frequent number of special events during study period (weddings, concerts, exams, etc.)

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04117347). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.